Document is current
Any future updates will be listed below
-
Authors
Byrne, Hilary L. http://orcid.org/0000-0001-7023-7976
Steiner, Elisabeth
Booth, Jeremy
Lamoury, Gillian
Morgia, Marita
Richardson, Kylie
Ambrose, Leigh
Makhija, Kuldeep
Stanton, Cameron
Zwan, Benjamin
Bromley, Regina
Atyeo, John
Silvester, Shona
Plant, Natalie
Keall, Paul
-
Funding
Funding for this research was provided by:
national health and medical research council (APP1073772)
national breast cancer foundation (PS-17-055)
- License Information
-
More Information
Article History
Received: 4 August 2021
Accepted: 3 January 2023
First Online: 22 February 2023
Declarations
:
: The protocol for this clinical trial has been reviewed and approved on 19 June 2015 by the Northern Sydney Local Health District Human Research Ethics Committee (HREC). This HREC is constituted and operates in accordance with the National Health and Medical Research Council’s ‘National Statement on Ethical Conduct in Human Research’ and the CPMP/ICH Note for Guidance on Good Clinical Practice. All patients must provide written informed consent before being enrolled in the trial.
: Not applicable.
: ES, KM and PK are inventors on a patent filed for the Breathe Well technology. KM and PK are founders, shareholders and directors of Opus Medical Pty Ltd, a company advancing the Breathe Well audiovisual biofeedback device.
